Isracann Biosciences Provides Bi-Weekly Default Status Report
Isracann Biosciences Inc.
VANCOUVER, British Columbia, Oct. 13, 2022 (GLOBE NEWSWIRE) — Isracann Biosciences Inc. (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the Company) announces that further to its…